Do All Beta Blockers provide the Same Magnitude of Clinically Convincing Mortality Benefits in Chronic Heart Failure Patients? : A Literature Review
Martin Mumuni Danaah Malick1 1. Department of Pharmacology; School of Medicine and Health Sciences;
Martin Mumuni Danaah Malick1 1. Department of Pharmacology; School of Medicine and Health Sciences;
Isaiah Amoo1, James Oppong-Kyekyeku*1, Eric Boakye-Gyasi2 & Samuel Asare-Nkansah1 1. Department of Pharmaceutical Chemistry,
Michael Mireku Opoku1, *Harriet Affran Bonful1,2, Kwadwo A. Koram3 1 Department of Epidemiology and
Yaa Adubea1, James Mercer Prempeh1, Sylvester Mawunyo Amaglo1, Dzifa Thywill Gordor1, Mariam Adoley Pappoe1, Peace
John K. A. Korbuvi1*, Harrison Awuttey1 1.Ho Teaching Hospital, Pharmacy Department, P. O. Box
Joseph Owusu-Ansah1 1.Ho Teaching Hospital, Ho, Volta Region. Corresponding author: jonkorbu@yahoo.com
Joseph Owusu-Ansah1 1.School of Public Health, KNUST, Kumasi Corresponding author: joepharm15@gmail.com
Delese Darko1, Olivia Boateng2, Seth Seneake 3, Radolf Nortey 2 1.Food and Drugs Authority,
Isaac Ayensu1*, Samuel Oppong Bekoe1,Joseph Kwasi Adu1,Abena Amponsaa Brobbey1, Enoch Appiah1 1. Department of
B.A. Adapalala1*, A. Amalba2, A. Hamidu3 1Pharmacy Directorate, Tamale Teaching Hospital, Tamale, Northern Region,